Cholesterol Testing - Global Strategic Business Report

The global market for Cholesterol Testing is estimated at US$23.3 Billion in 2023 and is projected to reach US$31.7 Billion by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The trend toward point-of-care (POC) cholesterol testing is growing, providing immediate results that facilitate timely discussions between healthcare providers and patients about treatment options. This trend is particularly beneficial in community health settings and pharmacies. Furthermore, there is a rising consumer-driven movement towards personal health monitoring, which has spurred the growth of over-the-counter cholesterol testing kits and wearable health devices. Preventive health management programs, supported by employers and insurance companies, are also incorporating cholesterol testing to improve employee health outcomes and reduce healthcare costs by addressing potential health issues early.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Diagnostic Centers End-Use segment, which is expected to reach US$11.6 Billion by 2030 with a CAGR of a 5.7%. The Physicians / Providers & Hospitals End-Use segment is also set to grow at 4.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $6.7 Billion in 2023, and China, forecasted to grow at an impressive 7.8% CAGR to reach $5.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Cholesterol Testing Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cholesterol Testing Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Cholesterol Testing Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Laboratories, AccuTech LLC, Akers Biosciences Inc., and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 42 Featured):

• Abbott Laboratories
• AccuTech LLC
• Akers Biosciences Inc.
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Boston Heart Diagnostics Corporation
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Home Access Health Corporation
• Laboratory Corporation of America® Holdings
• PTS Diagnostics
• Quest Diagnostics Inc.
• Randox Laboratories Ltd.
• Sekisui Diagnostics LLC
• Siemens Healthineers
• Sigma-Aldrich Corp.